Special Issue "Long-term Cancer Survivorship"
A special issue of Journal of Personalized Medicine (ISSN 2075-4426).
Deadline for manuscript submissions: closed (30 May 2015)
Prof. Dr. Jane M. Armer
Sinclair School of Nursing, Ellis Fischel Cancer Center, University of Missouri–Columbia, Columbia, MO, USA
Website | E-Mail
Interests: long-term cancer survivorship; living well after cancer; overall adjustment following cancer diagnosis and treatment; biopsychosocial factors associated with well-being following cancer; post-breast cancer lymphedema assessment and management
Cancer is a complex disease. Because of successes in screening, early detection, and individualized oncology treatments, cancer is increasingly seen as a chronic condition. Both acute treatment and long-term management require the dedication of a multidisciplinary team of clinicians and researchers, as well as continuing patient engagement and empowerment.
This Special Issue on survivorship focuses on the long-term aspects of living with cancer, and covers a time period from diagnosis, through treatment, and into the years beyond. Topics span biopsychosocial factors, the self-management of symptoms and co-morbidities, lifestyle changes, future survivorship risks, and considerations at the individual, family, and health system levels.
Prof. Dr. Jane M. Armer
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 550 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.